Jérémy Charriot

661 total citations
25 papers, 195 citations indexed

About

Jérémy Charriot is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology and Allergy. According to data from OpenAlex, Jérémy Charriot has authored 25 papers receiving a total of 195 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 15 papers in Physiology and 5 papers in Immunology and Allergy. Recurrent topics in Jérémy Charriot's work include Asthma and respiratory diseases (15 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers) and Respiratory and Cough-Related Research (7 papers). Jérémy Charriot is often cited by papers focused on Asthma and respiratory diseases (15 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers) and Respiratory and Cough-Related Research (7 papers). Jérémy Charriot collaborates with scholars based in France, United Kingdom and Canada. Jérémy Charriot's co-authors include Arnaud Bourdin, Isabelle Vachier, Pascal Chanez, A. Petit, Carey Suehs, Camille Taillé, Marc Humbert, A. Didier, Gilles Garcia and C. Pribil and has published in prestigious journals such as Biochemical and Biophysical Research Communications, European Respiratory Journal and European Journal of Immunology.

In The Last Decade

Jérémy Charriot

23 papers receiving 191 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jérémy Charriot France 8 115 109 41 29 25 25 195
Takao Mochimaru Japan 7 91 0.8× 126 1.2× 26 0.6× 24 0.8× 41 1.6× 12 183
Francesco Bianchi Italy 8 111 1.0× 89 0.8× 26 0.6× 5 0.2× 22 0.9× 14 198
D.Yu. Ovsyannikov Russia 7 89 0.8× 49 0.4× 42 1.0× 17 0.6× 5 0.2× 105 147
Fulvia Chieco Bianchi Italy 8 81 0.7× 80 0.7× 35 0.9× 42 1.4× 17 0.7× 11 180
Rasol Molatefi Iran 8 34 0.3× 57 0.5× 21 0.5× 43 1.5× 46 1.8× 15 166
Chris RuiWen Kuo United Kingdom 9 172 1.5× 219 2.0× 12 0.3× 70 2.4× 24 1.0× 27 272
Takahiro Ninomiya Japan 8 52 0.5× 229 2.1× 70 1.7× 215 7.4× 34 1.4× 19 355
Elisabetta Favero Italy 5 50 0.4× 62 0.6× 13 0.3× 35 1.2× 23 0.9× 8 135
Hee-Kyoo Kim South Korea 7 27 0.2× 123 1.1× 121 3.0× 40 1.4× 158 6.3× 23 287
Ayşe Süleyman Türkiye 7 32 0.3× 74 0.7× 7 0.2× 48 1.7× 15 0.6× 25 180

Countries citing papers authored by Jérémy Charriot

Since Specialization
Citations

This map shows the geographic impact of Jérémy Charriot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérémy Charriot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérémy Charriot more than expected).

Fields of papers citing papers by Jérémy Charriot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jérémy Charriot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérémy Charriot. The network helps show where Jérémy Charriot may publish in the future.

Co-authorship network of co-authors of Jérémy Charriot

This figure shows the co-authorship network connecting the top 25 collaborators of Jérémy Charriot. A scholar is included among the top collaborators of Jérémy Charriot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jérémy Charriot. Jérémy Charriot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
López, Antonio Fernández, Julien Frandon, Salma Adham, et al.. (2025). AI-Standardized Clinical Examination Training on OSCE Performance. NEJM AI. 2(8). 2 indexed citations
2.
Charriot, Jérémy, Lydia Finney, Freda Yang, et al.. (2025). Breathing barriers: bridging lung health, research, and awareness. The Lancet Respiratory Medicine. 13(8). 665–667. 2 indexed citations
3.
Charriot, Jérémy, M. Zysman, Laurent Guilleminault, et al.. (2023). Sputum-Rheology-Based Strategy for Guiding Azithromycin Prescription in COPD Patients with Frequent Exacerbations: A Randomized, Controlled Study (“COPD CARhE”). Biomedicines. 11(3). 740–740. 2 indexed citations
4.
Charriot, Jérémy, et al.. (2023). Multiple Biologics for Multiple T2 Diseases: A Pharmacoepidemiological Algorithm for Sorting Out Patients by Indication. Journal of Asthma and Allergy. Volume 16. 1287–1295.
5.
Daubin, Delphine, Jérémy Charriot, Kada Klouche, et al.. (2023). Mid-Term Sequelae of Surviving Patients Hospitalized in Intensive Care Unit for COVID-19 Infection: The REHCOVER Study. Journal of Clinical Medicine. 12(3). 1000–1000. 4 indexed citations
6.
Fieux, M., Florent Carsuzaa, Jérémy Charriot, et al.. (2023). Cross-Cultural Adaptation of the CRS-PRO Questionnaire into French. Journal of Otolaryngology - Head and Neck Surgery. 52(1). 77–77. 3 indexed citations
7.
Gouzi, Farès, Jérémy Charriot, Clément Boissin, et al.. (2022). Feasibility of a nasal breathing training during pulmonary rehabilitation. A pilot randomized controlled study. Respiratory Physiology & Neurobiology. 308. 103987–103987. 5 indexed citations
8.
Vialaret, Jérôme, Christophe Hirtz, A. Petit, et al.. (2022). Rheology predicts sputum eosinophilia in patients with muco-obstructive lung diseases. Biochemical and Biophysical Research Communications. 622. 64–71. 9 indexed citations
9.
Suehs, Carey, Khuder Alagha, Arnaud Bourdin, et al.. (2021). Anti-interleukin 5 therapies failure criteria in severe asthma: a Delphi-consensus study. Therapeutic Advances in Respiratory Disease. 15. 2663629063–2663629063. 2 indexed citations
10.
Bommart, Sébastien, Jérémy Charriot, Nicolas Nagot, et al.. (2021). Differentiating between active and latent tuberculosis with chest computed tomography. Diagnostic and Interventional Imaging. 102(10). 605–610. 11 indexed citations
11.
12.
Charriot, Jérémy, et al.. (2021). “Real-life” management of patients with severe asthma in the biologics era: Can we do better?. World Allergy Organization Journal. 14(4). 100528–100528. 4 indexed citations
13.
Bourrain, J.‐L., et al.. (2020). The six million dollar man. ERJ Open Research. 7(1). 341–2020. 2 indexed citations
14.
Suehs, Carey, et al.. (2020). PD-L1 inhibitor-induced worsening of eosinophilic obstructive lung disease successfully rescued with anti-interleukin 5 receptor (IL-5R) therapy. The Journal of Allergy and Clinical Immunology In Practice. 9(1). 567–569. 4 indexed citations
15.
Taillé, Camille, Pascal Chanez, Gilles Devouassoux, et al.. (2020). Mepolizumab in a population with severe eosinophilic asthma and corticosteroid dependence: results from a French early access programme. European Respiratory Journal. 55(6). 1902345–1902345. 56 indexed citations
16.
Bourdin, Arnaud, Jérémy Charriot, Clément Boissin, et al.. (2020). Will the asthma revolution fostered by biologics also benefit adult ICU patients?. Allergy. 76(8). 2395–2406. 4 indexed citations
17.
Petit, A., Jérémy Charriot, Martine Pugnière, et al.. (2019). CCSP counterbalances airway epithelial-driven neutrophilic chemotaxis. European Respiratory Journal. 54(1). 1802408–1802408. 15 indexed citations
18.
Gras, Delphine, A. Petit, Jérémy Charriot, et al.. (2017). Epithelial ciliated beating cells essential for ex vivo ALI culture growth. BMC Pulmonary Medicine. 17(1). 80–80. 23 indexed citations
19.
Charriot, Jérémy, Isabelle Vachier, Anne‐Sophie Gamez, et al.. (2016). Future treatment for asthma. European Respiratory Review. 25(139). 77–92. 14 indexed citations
20.
Charriot, Jérémy, Anne Sophie Gamez, Marc Humbert, Pascal Chanez, & Arnaud Bourdin. (2013). Thérapies ciblées dans l’asthme sévère : À la découverte de nouvelles molécules. Revue des Maladies Respiratoires. 30(8). 613–626. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takao Mochimaru Breakdown of academic impact, for papers by Francesco Bianchi Breakdown of academic impact, for papers by D.Yu. Ovsyannikov Breakdown of academic impact, for papers by Fulvia Chieco Bianchi Breakdown of academic impact, for papers by Rasol Molatefi Breakdown of academic impact, for papers by Chris RuiWen Kuo Breakdown of academic impact, for papers by Takahiro Ninomiya Breakdown of academic impact, for papers by Elisabetta Favero Breakdown of academic impact, for papers by Hee-Kyoo Kim Breakdown of academic impact, for papers by Ayşe Süleyman
Rankless by CCL
2026